Anzeige
Mehr »
Login
Dienstag, 14.05.2024 Börsentäglich über 12.000 News von 688 internationalen Medien
Uran-Rallye: Preise ziehen wieder an - Jetzt nicht den Einstieg verpassen
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Übersicht Suchergebnisse zum Thema H. LUNDBECK

ZeitNachrichten
Sprache: Alle DE EN
LeserMedien
MoH LUNDBECK A/S: Maria Alfaiate appointed new Executive Vice President Commercial and Corporate Strategy at Lundbeck2
07.05.A surprise leader for April's largest TV drug ad spender as Otsuka, Lundbeck knock AbbVie from its perch6
24.04.GSK, Lundbeck, ROVI: Three Journeys of Unified Pharma Events Management9
09.04.H LUNDBECK A/S: Lundbeck and Otsuka submit sNDA for FDA review of brexpiprazole and sertraline combination as potential treatment for PTSD88
28.03.Otsuka and Lundbeck's schizophrenia treatment gains EC approval4
27.03.H LUNDBECK A/S: Abilify Maintena[®] 960 mg (aripiprazole) approved in the EU as the first once-every-two-months long-acting injectable for the maintenance treatment of schizophrenia1
20.03.H LUNDBECK A/S: Lundbeck held its Annual General Meeting on 20 March 2024 at the company's registered office2
15.03.H LUNDBECK A/S: Lundbeck's potential first-in-class therapy for migraine prevention enters advanced clinical stage2
06.03.Lundbeck Foundation: -Pionierarbeit auf dem Gebiet der rechnergestützten und theoretischen Neurowissenschaften wird mit dem weltweit größten Preis für Hirnforschung ausgezeichnet409Die Professoren Larry Abbott, Terrence Sejnowski und Haim Sompolinsky haben Pionierarbeit auf dem Gebiet der rechnergestützten und theoretischen Neurowissenschaften geleistet und entscheidende Beiträge...
► Artikel lesen
05.03.Lundbeck Foundation: Pioneering work in computational and theoretical neuroscience is awarded the world's largest brain research prize269Professors Larry Abbott, Terrence Sejnowski, and Haim Sompolinsky have pioneered the field of computational and theoretical neuroscience and made seminal contributions to our understanding of the...
► Artikel lesen
05.03.H LUNDBECK A/S: Lundbeck presents encouraging results from the Lu AF82422 trial for Multiple System Atrophy at the international AD/PD 2024 conference on neurodegenerative disorders3
23.02.H LUNDBECK A/S: Notice of Annual General Meeting2
23.02.H LUNDBECK A/S: Lundbeck announces changes to Executive Management4
16.02.H LUNDBECK A/S: Transactions with shares and linked securities in H. Lundbeck A/S made by executives and their closely associated parties3
13.02.DB upgrades Lundbeck to 'buy' on promising drug prospects in 202410
07.02.H LUNDBECK A/S: Transactions with shares and linked securities in H. Lundbeck A/S made by executives and their closely associated parties7
07.02.H LUNDBECK A/S: Lundbeck Annual Report 20239
05.02.H LUNDBECK A/S: Dianne Hol appointed new Executive Vice President People & Organization at Lundbeck2
01.02.Lundbeck study knocks confidence in alpha-syn as CNS target4
31.01.H LUNDBECK A/S: Lundbeck announces supportive phase II results with Lu AF82422 in the treatment of Multiple System Atrophy from the AMULET trial4
Seite:  Weiter >>